Comparison of Tele-Critical Care Versus Usual Care On ICU Performance: A Cluster Randomized Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Critical Care
- Sponsor
- Hospital Israelita Albert Einstein
- Enrollment
- 19360
- Locations
- 1
- Primary Endpoint
- Intensive Care Unit Length of Stay
- Last Updated
- 4 years ago
Overview
Brief Summary
TELESCOPE will be a cluster randomized clinical trial to ascertain whether the use of an intervention including multidisciplinary round with a board certified physician through tele-critical care and periodic meetings to discuss strategies to improve quality indicators can reduce ICU length of stay of patients admitted to intensive care units (ICUs).
Detailed Description
Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization. The trial will have two stages: Stage I - Baseline data: * Characterize participant ICUs and quality indicators * Characterize patients from each participant ICU to describe baseline outcomes Stage II - Intervention: This is the main stage for data analysis. ICUs will be randomly assigned to an experimental or control group. The experimental group should use a multidisciplinary rounds with a board certified physician through tele-critical care and take part in meetings to discuss how to improve local quality indicators, and the control group will follow the local standard of care.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Intensive Care Unit Length of Stay
Time Frame: From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Time until discharge from the intensive care unit
Secondary Outcomes
- In-Hospital Mortality(From date of randomization until the date of hospital discharge or death, whichever comes first, assessed up to 90 days)
- Incidence Density of Urinary Tract Infection Associated with Catheter(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Patient-Days Receiving Oral or Enteral Feeding(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Patient-Days Under Light Sedation or Alert and Calm(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Standardized Resource Use(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Standardized Mortality Rate(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Incidence Density of Central Line-Associated Bloodstream Infection (CLABSI)(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Incidence Density of Ventilator-Associated Pneumonia (VAP)(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)
- Ventilator-Free Days at Day 28(28 Days)
- Rate of Patients Under Normoxia(From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days)